Search

Your search keyword '"Timothy O. Wilson"' showing total 7 results
Start Over Author "Timothy O. Wilson" Publication Year Range Last 3 years

Refine your results

7 results on '"Timothy O. Wilson"'

1. Supplementary Figure 1 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Author

Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, and Evanthia Galanis

Abstract

Supplementary Figure 1 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Published
2023

2. Supplementary Figure 4 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Author

Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, and Evanthia Galanis

Abstract

Supplementary Figure 4 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Published
2023

3. Supplementary Figure 2 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Author

Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, and Evanthia Galanis

Abstract

Supplementary Figure 2 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Published
2023

4. Supplementary Figure Legends 1-5 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Author

Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, and Evanthia Galanis

Abstract

Supplementary Figure Legends 1-5 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Published
2023

5. Supplementary Figure 5 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Author

Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, and Evanthia Galanis

Abstract

Supplementary Figure 5 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Published
2023

6. Supplementary Figure 3 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Author

Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, and Evanthia Galanis

Abstract

Supplementary Figure 3 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Published
2023

7. Supplementary Table 1 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Author

Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Timothy O. Wilson, C. Robert Stanhope, Sean C. Dowdy, Karl C. Podratz, Pamela J. Atherton, Gary Keeney, Jeff A. Sloan, Paula J. Zollman, Ileana Aderca, Paul J. Haluska, Judith S. Kaur, Brigitte A. Barrette, Prema P. Peethambaram, Harry J. Long, William A. Cliby, Lynn C. Hartmann, and Evanthia Galanis

Abstract

Supplementary Table 1 from Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

Published
2023

Catalog

Books, media, physical & digital resources
See catalog results